These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16557042)

  • 21. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From "Candy Kids" to "Chemi-Kids": a typology of young adults who attend raves in the midwestern United States.
    McCaughan JA; Carlson RG; Falck RS; Siegal HA
    Subst Use Misuse; 2005; 40(9-10):1503-23. PubMed ID: 16048830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ecstasy (MDMA): alerting users to the dangers.
    Cook A
    Nurs Times; 1995 Apr 19-25; 91(16):32-3. PubMed ID: 7731854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling the adverse effects associated with ecstasy use.
    Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F
    Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MDMA or ecstasy: pharmacologic, toxicologic and clinical aspects].
    Prada C; Alvarez FJ
    Med Clin (Barc); 1996 Oct; 107(14):549-55. PubMed ID: 8999216
    [No Abstract]   [Full Text] [Related]  

  • 26. An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users.
    Pirona A; Morgan MJ
    J Psychopharmacol; 2010 Feb; 24(2):175-85. PubMed ID: 19351799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ecstasy, a new designer drug in the techno-scene].
    Kuhlmann T
    Psychiatr Prax; 1996 Nov; 23(6):266-9. PubMed ID: 9036394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor.
    Hanson KL; Luciana M
    J Clin Exp Neuropsychol; 2010 Apr; 32(4):337-49. PubMed ID: 20397296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylenedioxymethamphetamine (ecstasy)-related hyperthermia.
    Patel MM; Belson MG; Longwater AB; Olson KR; Miller MA
    J Emerg Med; 2005 Nov; 29(4):451-4. PubMed ID: 16243206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Partying" hard: party style, motives for and effects of MDMA use at rave parties.
    M ter Bogt TF; Engels RC
    Subst Use Misuse; 2005; 40(9-10):1479-502. PubMed ID: 16048829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in drug use among electronic dance music party attendees in New York City, 2016-2019.
    Palamar JJ; Keyes KM
    Drug Alcohol Depend; 2020 Apr; 209():107889. PubMed ID: 32050110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects on rat sexual behaviour of acute MDMA (ecstasy) alone or in combination with loud music.
    Cagiano R; Bera I; Sabatini R; Flace P; Vermesan D; Vermesan H; Dragulescu SI; Bottalico L; Santacroce L
    Eur Rev Med Pharmacol Sci; 2008; 12(5):285-92. PubMed ID: 19024211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of increased activation underlying cognitive control in ecstasy and cannabis users.
    Roberts GM; Garavan H
    Neuroimage; 2010 Aug; 52(2):429-35. PubMed ID: 20417713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration.
    McNamara R; Maginn M; Harkin A
    Eur J Pharmacol; 2007 Jan; 555(2-3):194-8. PubMed ID: 17126829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome expectancies and ecstasy use in visitors of rave parties in The Netherlands.
    Engels RC; ter Bogt T
    Eur Addict Res; 2004; 10(4):156-62. PubMed ID: 15367816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is ecstasy a drug of dependence?
    Degenhardt L; Bruno R; Topp L
    Drug Alcohol Depend; 2010 Feb; 107(1):1-10. PubMed ID: 19836170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The rise of club drugs in a heroin society: the case of Hong Kong.
    Joe Laidler KA
    Subst Use Misuse; 2005; 40(9-10):1257-78. PubMed ID: 16048816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ecstasy is making a comeback, European drugs report warns.
    Watson R
    BMJ; 2016 May; 353():i3078. PubMed ID: 27245254
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.